4). However, the possible presence of ciliated cells SP600125 datasheet in absence of detectable mucus secretions might suggest a bronchiolar origin for RL-65 cells. These cell layers also exhibited TEER ∼250–600 Ω cm2 (Fig. 1), i.e., in the same

range as Calu-3 (Borchard et al., 2002 and Fiegel et al., 2003), 16HBE14o- (Forbes et al., 2003) and NHBE (Lin et al., 2007 and Madlova et al., 2009) layers. 14C-mannitol permeability across the layers was measured as ∼3.0 × 10−6 cm/s (Table 1). Although higher than reported for Calu-3 (Forbes and Ehrhardt, 2005) and NHBE (Madlova et al., 2009) cell layers, this value is comparable to paracellular transport data published in 16HBE14o- layers (Ehrhardt et al., 2002 and Forbes et al., 2003). RL-65 layers at an early passage (3–4) achieved higher TEER values than at a later passage (6–18), suggesting an alteration in Libraries barrier properties with increasing passage number. A similar trend has also been reported for NHBE cell layers which lose the ability selleck chemicals to form a permeability barrier after 3–4 passages

(Widdicombe et al., 2005). In comparison to NHBE cells, the RL-65 cell line nevertheless provides an extended passage window for use in drug permeability measurements. Gene expression analysis of selected drug transporters revealed the presence of octn2 and mdr1b in RL-65 cell layers (Table 2). This is in agreement with the high expression of OCTN2 in the human bronchial epithelium (Horvath et al., 2007) and the for higher levels of mdr1b as compared to mdr1a transcripts detected in rat lungs (Brown et al., 1993 and Brady et al., 2002), respectively. Additionally, apical expression of P-gp was confirmed in RL-65 cell layers by immunocytochemistry (Fig. 6), in accordance with its localisation in rat bronchial epithelial tissue (Campbell et al., 2003).

However, no apparent efflux of 3H-digoxin and Rh123 was observed across the layers (Fig. 7). As both compounds are substrates for the two P-gp isoforms (mdr1a/b) found in rats (Schinkel et al., 1997, Takeuchi et al., 2006 and Suzuyama et al., 2007), our data suggests the transporter was not functional in 8-day old RL-65 cell layers. The presence of functional P-gp in human bronchial epithelial cell culture models remains controversial to date (Bosquillon, 2010). Several studies have concluded the transporter was responsible for the apparent efflux of various substrates in NHBE, 16HBE14o- or Calu-3 cell layers (Lin et al., 2007, Ehrhardt et al., 2003, Hamilton et al., 2001, Patel et al., 2002 and Brillault et al., 2009) while others have reported an absence of P-gp in Calu-3 layers (Cavet et al., 1997) or a negligible impact on drug transport in the Calu-3 and NHBE models (Madlova et al., 2009 and Hutter et al., 2011). Although 3H-digoxin is a recommended substrate probe for P-gp (Rautio et al., 2006 and Huang et al.